Both in Pharmaceuticals
GRI Bio vs KALA BIO
Over the past year GRI returned −97.0% and KALA returned −99.6%; their daily moves had a correlation of 0.03.
GRI −97.0% KALA −99.6%Growth of $1, one year, split-adjusted
| Metric | GRI | KALA |
|---|---|---|
| Price | $1.57 | $0.1751 |
| Market cap | $3.4M | $3.4M |
| Today | −3.38% | −2.67% |
| 1 month | −18.7% | −59.2% |
| 6 months | −28.0% | −96.7% |
| Year to date | −77.3% | −99.4% |
| 1 year | −97.1% | −99.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $10.9M | $7.2M |
| Dividend yield | — | — |
| Volatility (60d) | 134.4% | 123.6% |
| Short % of float | 3.0% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).